Literature DB >> 21926146

Biological evaluation of nano-hydroxyapatite-zirconia (HA-ZrO2) composites and strontium-hydroxyapatite (Sr-HA) for load-bearing applications.

Ian Brook1, Christine Freeman, Sarah Grubb, Niamh Cummins, Declan Curran, Colin Reidy, Stuart Hampshire, Mark Towler.   

Abstract

The biological response of strontium (Sr) doped hydroxyapatite (HA) and hydroxyapatite-zirconia (HA-ZrO₂) composites produced by employing sol-gel technology, minimal ZrO₂ loadings, and novel microwave-sintering regimes thereby retarding decomposition, is reported. In vitro evaluations indicate that all materials induce a favorable response from rat osteosarcoma cells. In vivo evaluations show osteoconductivity and biocompatibility for both the Sr-HA and HA-ZrO₂. The materials did not cause any inflammatory response in bone. The Sr-HA displays better biocompatibility which may be due to the incorporation of Sr and the formation of a surface apatite layer.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21926146     DOI: 10.1177/0885328211403020

Source DB:  PubMed          Journal:  J Biomater Appl        ISSN: 0885-3282            Impact factor:   2.646


  3 in total

1.  Investigating the effect of SiO2-TiO 2-CaO-Na 2O-ZnO bioactive glass doped hydroxyapatite: characterisation and structural evaluation.

Authors:  Chokchai Yatongchai; Anthony W Wren; Declan J Curran; Stuart Hampshire; Mark R Towler
Journal:  J Mater Sci Mater Med       Date:  2014-04-19       Impact factor: 3.896

Review 2.  Calcium Orthophosphate-Containing Biocomposites and Hybrid Biomaterials for Biomedical Applications.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2015-08-07

3.  Alveolar bone repair with strontium- containing nanostructured carbonated hydroxyapatite.

Authors:  André Boziki Xavier do Carmo; Suelen Cristina Sartoretto; Adriana Terezinha Neves Novellino Alves; José Mauro Granjeiro; Fúlvio Borges Miguel; Jose Calasans-Maia; Monica Diuana Calasans-Maia
Journal:  J Appl Oral Sci       Date:  2018-01-18       Impact factor: 2.698

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.